Clinical Trials Directory

Trials / Completed

CompletedNCT00980980

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74,256 (actual)
Sponsor
Harvard Pilgrim Health Care · Academic / Other
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies to be evaluated are: * screening on admission followed by isolation of MRSA+ patients * screening on admission followed by isolation and decolonization of MRSA+ patients * universal decolonization on admission with no screening. The decolonization regimen involves bathing with chlorhexidine plus intra-nasal application of mupirocin. The main outcome will be MRSA+ clinical cultures. The study is a partnership between the CDC, the CDC Prevention Epicenters, and the Hospital Corporation of America.

Detailed description

Baseline data involving 12 months of data for participating hospitals (July 2008 - June 2009) was collected prior to randomization to account for size and ICU baseline prevalence of MRSA in randomization scheme. Randomization occurred at the hospital level. Eligibility survey was conducted to determine exclusion criteria. As of May 2010, enrollment has been closed. 45 hospitals were randomized, but two were found to meet exclusion criteria and were excluded. As-randomized (or as-assigned) analysis included 43 hospitals, representing 74 ICUs. Individual (patient-level) subject enrollment during intervention is 74,256.

Conditions

Interventions

TypeNameDescription
DRUGChlorhexidine bath and nasal mupirocinThe intervention / decolonization regimen will consist of the most commonly used topical regimen in the US - a combination of daily baths with 2% chlorhexidine cloths , plus 5 days of topical intranasal mupirocin ointment (bilateral nares, twice daily)

Timeline

Start date
2009-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2009-09-21
Last updated
2017-05-02
Results posted
2014-07-30

Locations

42 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00980980. Inclusion in this directory is not an endorsement.